Categories
Sandu Pharmaceuticals Ltd — Board Meeting, 05-05-2026: Board Meeting
05-05-2026 · 06:02 pm
Sandu Pharma's Board approved Q4 & FY26 results. Annual revenue ₹14.07 Cr, profit ₹0.98 Cr. The company proposes a final dividend of ₹1 per share. New Cost & Internal Auditors for FY27 appointed.
No comments yet. Be the first to comment!